Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Gianakakos Anastasios, Director. Officer active across 1 company, notably LianBio. Aggregated, 2 disclosures have been recorded. History available since 29 December 2021. The latest transaction was disclosed on 15 February 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Anastasios Gianakakos is a Director at LianBio. As a board member, he participates in overseeing the company's operations and making strategic decisions. Anastasios brings significant expertise in the biopharmaceutical sector, allowing him to contribute to the growth and profitability of LianBio. His commitment to corporate governance ensures strong and responsible leadership.